ACM  >> Vol. 6 No. 3 (September 2016)

    低分子肝素钙对恶性肿瘤患者D-二聚体和PICC管堵塞的影响
    Effect of Low Molecular Weight Heparin on D-Dimer and PICC Tube Blockage of Malignant Cancer Patients

  • 全文下载: PDF(463KB) HTML   XML   PP.128-131   DOI: 10.12677/ACM.2016.63023  
  • 下载量: 1,006  浏览量: 2,075  

作者:  

陈雅萍,顾枫琳,华棋燕,董柏年:浙江萧山医院,浙江 杭州

关键词:
低分子肝素钙恶性肿瘤D-二聚体PICC导管Low Molecular Weight Heparin Malignant Cancer D-Dimer PICC Tube

摘要:

目的:探讨低分子肝素钙对恶性肿瘤患者D-二聚体和PICC管堵塞的影响,及抗凝治疗对PICC导管堵塞的干预效果。方法:选择D-二聚体偏高并置有PICC导管的恶性肿瘤患者30例,随机分为两组,测定15例(治疗组)接受低分子肝素钙治疗后D-二聚体的变化,同时检测15例(对照组) D-二聚体值进行对比观察。结果:与治疗前比较,低分子肝素治疗组在治疗后的2、4和7天的降低率为49.22%、50.18%和61.92%;对照组患者的D-二聚体在治疗后2、4和7天的降低率为6.00%、22.13%和13.57%。治疗组的下降率高于对照组。同时,低分子肝素治疗组抗凝后出现1例PICC导管堵塞,堵管率为6.67%,对照组出现10例PICC导管堵塞,堵管率为66.67%。结论:恶性肿瘤患者存在血液高凝及凝血功能紊乱,经低分子肝素钙治疗后可明显改善症状,降低血浆D-二聚体水平,同时减少PICC导管的堵塞,值得临床推广和应用。

Objective: To investigate the effect of low molecular weight heparin in patients with cancer D- dimer and PICC tube blockage, and anticoagulation effect of interference PICC catheter blockage. Methods: D-dimer High malignancy in patients with PICC catheter 30 patients were randomly divided into two groups, measured 15 cases (treatment group) accept change after low molecular weight heparin therapy D-dimer, while detected 15 cases (control group) D-dimer values were compared. Results: The treatment with relatively low molecular weight heparin in the treat- ment group at 2, 4 and 7 days after treatment reduced rate of 49.22%, 50.18% and 61.92%; the control group of patients after treatment 2,4 D-dimer and 7 days reduced rate of 6.00%, 22.13% and 13.57%. The rate of decline in treatment group is higher than the control group. Meanwhile, the low molecular weight heparin anticoagulant therapy group 1 case PICC catheter blockage, plugging rate of 6.67% in the control group had 10 cases of PICC catheter obstruction, plugging rate was 66.67%. Conclusion: Cancer patients hypercoagulable and coagulation disorders, the low molecular weight heparin treatment can significantly improve symptoms, reduce plasma D-dimer levels, while reducing the PICC catheter blockage, worthy of promotion and application.

文章引用:
陈雅萍, 顾枫琳, 华棋燕, 董柏年. 低分子肝素钙对恶性肿瘤患者D-二聚体和PICC管堵塞的影响[J]. 临床医学进展, 2016, 6(3): 128-131. http://dx.doi.org/10.12677/ACM.2016.63023

参考文献

[1] 王秀华, 王丽娟. 三向瓣膜式外周中心静脉导管的置管及护理[J]. 中国实用护理杂志, 2003, 19(3): 245-247.
[2] 金莉, 刘鲁明. 血液高凝状态、血小板与恶性肿瘤及其转移的关系[J]. 实用肿瘤杂志, 2003, 18(5): 559-560.
[3] 王建莱. 输液治疗护理实践指南与实施细则[M]. 北京: 人民军医出版社, 2009: 11-123.
[4] 耿文英, 丁绍平, 孙荣艳, 等. 分子肝素钙在血液透析抗凝中的应用[J]. 中国全科医学, 2003, 6(10): 8731.
[5] 王延瑞, 王振才, 李晓. 低分子肝素钙的药理特性及临床应用[J]. 临床荟萃, 2008(18): 855-856.
[6] 陆森, 张海业, 陆粤就. 恶性肿瘤合并凝血功能障碍临床分析[J]. 中国现代医生, 2010, 48(23): 118-119.
[7] 中华医学会重症医学分会. ICU患者深静脉血栓形成预防指南[J]. 中国实用外科杂志, 2009, 29(10): 793.